![](/img/cover-not-exists.png)
American College of Rheumatology hybrid analysis of certolizumab pegol plus methotrexate in patients with active rheumatoid arthritis: Data from a 52-week phase III trial
R. F. van Vollenhoven, D. Felson, V. Strand, M. E. Weinblatt, K. Luijtens, E. C. KeystoneVolume:
63
Year:
2011
Language:
english
Pages:
7
DOI:
10.1002/acr.20331
File:
PDF, 101 KB
english, 2011